Home › Cancer sa Matris › Pennsylvania
Pag-aaral pangklinika para sa Cancer sa Matris sa Pennsylvania
7 pag-aaral para sa Cancer sa Matris ang naghahanap ng mga kalahok sa mga site sa Pennsylvania.
Mga Lungsod sa Pennsylvania
Opisyal na teksto ng pag-aaral (English)
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
- UPMC Vision Institute, Monroeville
- University Ear, Nose, & Throat Eye & Ear Institute, Pittsburgh
- UPMC Magee-Womens Hospital, Pittsburgh
- at 3 pa
Nagre-recruitPhase 4
Edad 18 pataas · Kababaihan · Na-update Set 25, 2026 · NCT06952660PROton Therapy for Post Surgical Treatment of GYNecologic Cancer
- Lancaster General Health - Ann B. Barshinger Cancer Institute, Lancaster
- University of Pennsylvania, Philadelphia
Nagre-recruitPhase 2
Edad 18 pataas · Kababaihan · Na-update Set 17, 2026 · NCT05758688DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
- Research Site, Philadelphia
- Research Site, Pittsburgh
Nagre-recruitPhase 3
Edad 18 pataas · Kababaihan · Na-update Set 3, 2026 · NCT06989112Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
- USOR Alliance Cancer Specialist, Doylestown
- Allegheny Health Network, Pittsburgh
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 4, 2026 · NCT05579366Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
- Research Site, Bethlehem
- Research Site, Hershey
- Research Site, Lancaster
- at 5 pa
Nagre-recruitPhase 3
Edad 18 pataas · Kababaihan · Na-update Hul 29, 2026 · NCT07044336A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Thomas Jefferson University, Philadelphia
Nagre-recruitPhase 2
Edad 8 pataas · Lahat ng kasarian · Na-update Hul 27, 2026 · NCT05503797[18F]FES PET/.CT in Uterine Cancer
- Abramson Cancer Center at University of Pennsylvania, Philadelphia
Nagre-recruitPhase 2
Edad 18 pataas · Kababaihan · Na-update Hun 5, 2026 · NCT05916196Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.